UMMS' Mello Bullish on RNAi Rx Field as Colleagues See Bright Future for miRNA Modulation

According to Nobel laureate Craig Mello, RNAi for research applications "really is very reliable and it works very well. I think where it was over-hyped is this notion that you can just give a patient RNA and expect them to get better."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.